ATWAX
Price
$28.71
Change
+$0.40 (+1.41%)
Updated
Jun 18 closing price
Net Assets
1.09B
RWBEX
Price
$81.76
Change
+$0.83 (+1.03%)
Updated
Jun 18 closing price
Net Assets
159.53B
Interact to see
Advertisement

ATWAX vs RWBEX

ATWAX vs RWBEX Comparison Chart in %
View a ticker or compare two or three
VS
ATWAX vs. RWBEX commentary
Jun 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATWAX is a Buy and RWBEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWBEX has more cash in the bank: 160B vs. ATWAX (1.09B). RWBEX pays higher dividends than ATWAX: RWBEX (0.96) vs ATWAX (0.86). ATWAX was incepted earlier than RWBEX: ATWAX (23 years) vs RWBEX (12 years). ATWAX (1.26) and RWBEX (1.21) have similar cost to investors . RWBEX is a more actively managed with annual turnover of: 44.00 vs. ATWAX (23.00). RWBEX has a lower initial minimum investment than ATWAX: RWBEX (250) vs ATWAX (2500). ATWAX annual gain was more profitable for investors over the last year : 24.09 vs. RWBEX (20.85). ATWAX return over 5 years is better than : 47.82 vs. RWBEX (34.55).
ATWAXRWBEXATWAX / RWBEX
Total Expense Ratio0.981.2181%
Annual Report Gross Expense Ratio1.261.21104%
Fund Existence23 years12 years-
Gain YTD12.14815.45979%
Front Load4%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.09B160B1%
Annual Yield % from dividends0.860.9689%
Returns for 1 year24.0920.85116%
Returns for 3 years59.8644.13136%
Returns for 5 years47.8234.55138%
Returns for 10 years114.7697.89117%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BOGSX11.820.36
+3.14%
Black Oak Emerging Technology
GGQPX22.890.19
+0.84%
Goldman Sachs Mid Cap Growth P
PUVCX44.200.23
+0.52%
Putnam International Small Cap C
FINVX16.820.07
+0.42%
Fidelity Series International Value
FHCIX64.570.17
+0.26%
Fidelity Advisor Health Care I